PM-19

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePM-19
Drug Alias NamePolyoxometalase 19
ClassificationOther
Mechanisms of ActionHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes SimplexHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGuineaJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTerumo +[2] 
Active IndicationsN/A
Inactive IndicationsHerpes SimplexHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A